Official AMFI data
Arthkar
ITI

ITI Pharma and Healthcare Fund

Sectoral / ThematicEquity SEBI-regulated

NAV (Direct-Growth)

₹19.3354

As of 3 Jul 2026 · AMFI

AUM

₹237.99 Cr

Expense ratio

0.68%

1Y returns

+7.64%

cat 12.11%

3Y CAGR

+21.46%

cat 22.73%

5Y CAGR

cat 13.72%

Std deviation 3Y

+16.61%

cat 16.29%

In plain English

ITI Pharma and Healthcare Fund is a Sectoral / Thematic scheme from ITI. The portfolio is ~98% in equities. 3-year CAGR: about 21.5%. Volatility is typical for equity — 20–30 % drawdowns happen during market stress. Worst historical drawdown: -18% in Jun 2022, recovered in 12 months. Wrong fit if you need this money in less than 7 years.

Auto-generated from holdings, returns and risk data. No paid placement, no copy-pasted boilerplate.

NAV history

NAV (Direct-Growth)

₹19.3354

Last 1Y

+8.23%

Jul 25Min ₹15.79 · Max ₹19.34 · 201 ptsJul 26

Drawdown stories

The crashes you should know about — and how long the fund took to recover.

Jun 2022

-17.7%

Peak ₹10.34 on 13 Jan 2022 → trough ₹8.51 on 17 Jun 2022 (5 months down).

Recovered in 12 months· 16 Jun 2023

Mar 2025

-17.1%

Peak ₹18.78 on 2 Jan 2025 → trough ₹15.58 on 3 Mar 2025 (2 months down).

Recovered in 16 months· 1 Jul 2026

Computed from the full NAV history. We show drawdowns deeper than 10%, sorted by depth.

Honesty score

A 1–5 grade on the dimensions other sites won't surface — expense bloat, AUM bloat, concentration, mandate compliance.

4

Honesty score

4 / 5

Solid scheme on the dimensions we check. No red flags.

  • Expense ratio

    0.68% — typical for category.

  • AUM size

    ₹238 Cr.

  • Sector concentration

    Top 3 sectors = 98.0% — heavy concentration risk.

Computed from expense ratio, AUM, sector concentration and SEBI mandate compliance. No paid review.

Performance

Returns for various periods, with category average and peer rank.

PeriodReturnsCategory avgRank
1W+2.99%+0.29%6/ 18
1M+6.56%+3.93%3/ 18
3M+9.29%+5.61%7/ 18
6M+11.31%+12.10%11/ 18
YTD+11.78%+11.97%11/ 18
1Y+7.64%+12.11%16/ 17
2Y+10.24%+12.10%12/ 14
3Y+21.46%+22.73%10/ 10
5Y+13.72%
7Y+19.14%
10Y+13.62%

Portfolio composition

Asset allocation

  • Equity98.01%
  • Cash1.99%

By market cap

  • Large cap47.29%
  • Mid cap30.11%
  • Small cap28.74%

Concentration

Holdings

39

Avg market cap

₹81.3K Cr

Top 10 stocks

58.94%

Top 5 stocks

38.84%

Top 3 sectors

98.01%

Top holdings

Top 15 positions by weight, latest disclosure.

#InstrumentSectorWeight
  • 1

    Sun Pharmaceuticals Industries Ltd

    14.25%
  • 1

    Sun Pharmaceuticals Industries Ltd

    11.80%
  • 2

    Divi's Laboratories Ltd

    8.77%
  • 2

    Divi's Laboratories Ltd

    8.43%
  • 3

    Apollo Hospitals Enterprise Ltd

    6.60%
  • 3

    Apollo Hospitals Enterprise Ltd

    6.20%
  • 4

    Max Healthcare Institute Ltd Ordinary Shares

    5.50%
  • 5

    Torrent Pharmaceuticals Ltd

    5.28%
  • 4

    Laurus Labs Ltd

    5.06%
  • 6

    Aurobindo Pharma Ltd

    4.99%
  • 5

    Torrent Pharmaceuticals Ltd

    4.90%
  • 6

    Max Healthcare Institute Ltd Ordinary Shares

    4.90%
  • 7

    Aurobindo Pharma Ltd

    4.28%
  • 7

    Lupin Ltd

    4.20%
  • 8

    Dr Reddy's Laboratories Ltd

    3.98%

Fundamentals (vs category)

Portfolio-weighted ratios, compared with the category average.

MetricFundCategory avgDiff
  • P/E ratio41.0241.09-0.07
  • P/B ratio5.625.83-0.21
  • Price / Sales5.725.71+0.01
  • Price / Cash Flow30.3530.54-0.19
  • Dividend yield0.58%0.63%-0.05
  • Return on equity (ROE)16.24%16.57%-0.33

Risk metrics

Standard deviation, Sharpe, Sortino, Beta — all vs category average.

Metric1Y3Y5YCat 1YCat 3YCat 5Y
  • Standard deviation

    Volatility — lower means steadier returns.

    16.6116.6114.9216.2915.44
  • Sharpe ratio

    Risk-adjusted return — higher is better.

    0.190.880.480.980.58
  • Sortino ratio

    Like Sharpe but only counts downside volatility.

    0.291.460.831.710.94
  • Beta

    1 = moves with the market. <1 = less volatile.

    1.030.980.940.950.94

Peers in Sectoral / Thematic

Other schemes in the same SEBI category, ranked by AUM.

Available plans & options

PlanOptionFull nameISIN
  • DirectGrowthITI Pharma and Healthcare Fund - Direct Plan - Growth OptionINF00XX01BO9
  • DirectIDCW ReinvestmentITI Pharma and Healthcare Fund - Direct Plan - IDCW OptionINF00XX01BP6
  • RegularGrowthITI Pharma and Healthcare Fund - Regular Plan - Growth OptionINF00XX01BL5
  • RegularIDCW ReinvestmentITI Pharma and Healthcare Fund - Regular Plan - IDCW OptionINF00XX01BM3